Cost-effectiveness of the sustained-release paclitaxel-eluting Eluvia stent compared to the paclitaxel-coated Zilver PTX stent for endovascular treatment of peripheral artery disease – a German Statutory Sickness Fund perspective

Authors:

Giretti C, Gray W, Elroy P, Akehurst R, Amorosi S, Griffiths R and Müller-Hülsbeck S.

Publication type:

Conference Proceedings – Poster

Publication Name:

ISPOR Europe 2019

Citation:

Giretti C, Gray W, Elroy P, Akehurst R, Amorosi S, Griffiths R and Müller-Hülsbeck S. Cost-effectiveness of the sustained-release paclitaxel-eluting Eluvia stent compared to the paclitaxel-coated Zilver PTX stent for endovascular treatment of peripheral artery disease – a German Statutory Sickness Fund perspective. 19th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Copenhagen, Denmark. 2-6 November 2019. PCV56.

Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies